4/A

FORM 4/A SUBMISSION

Company: Stoke Therapeutics, Inc.
Filed: May 26, 2020
Period of Report: December 16, 2019
Accession Number: 0001209191-20-032142

View Document ↗ View on SEC.gov ↗